NVO - Novo Nordisk A/S Stock Price and Quote

NVO [NYSE]

Index	-	P/E	44.99	EPS (ttm)	3.54	Insider Own	26.40%	Shs Outstand	2.28B	Perf Week	4.18%
Market Cap	273.91B	Forward P/E	30.43	EPS next Y	5.23	Insider Trans	0.00%	Shs Float	1.17B	Perf Month	10.82%
Income	8.07B	PEG	16.07	EPS next Q	1.15	Inst Own	8.40%	Short Float / Ratio	0.12% / 0.99	Perf Quarter	17.71%
Sales	25.73B	P/S	10.65	EPS this Y	17.80%	Inst Trans	-5.26%	Short Interest	1.40M	Perf Half Y	58.52%
Book/sh	5.33	P/B	29.86	EPS next Y	11.00%	ROA	24.70%	Target Price	151.93	Perf Year	41.41%
Cash/sh	1.99	P/C	79.91	EPS next 5Y	2.80%	ROE	73.70%	52W Range	95.02 - 158.11	Perf YTD	17.59%
Dividend	1.77	P/FCF	45.46	EPS past 5Y	9.70%	ROI	56.10%	52W High	0.65%	Beta	0.46
Dividend %	1.11%	Quick Ratio	0.70	Sales past 5Y	9.60%	Gross Margin	83.90%	52W Low	67.48%	ATR	2.66
Employees	54393	Current Ratio	0.90	Sales Q/Q	25.50%	Oper. Margin	42.30%	RSI (14)	77.08	Volatility	0.99% 1.48%
Optionable	Yes	Debt/Eq	0.31	EPS Q/Q	25.70%	Profit Margin	31.40%	Rel Volume	0.80	Prev Close	158.09
Shortable	Yes	LT Debt/Eq	0.29	Earnings	Feb 01 BMO	Payout	316.80%	Avg Volume	1.43M	Price	159.14
Recom	1.70	SMA20	8.79%	SMA50	11.56%	SMA200	31.63%	Volume	1,142,188	Change	0.66%

Jul-15-22

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Jun-28-22

Downgrade

UBS

Neutral → Sell

Jun-27-22

Upgrade

Exane BNP Paribas

Underperform → Neutral

Jun-07-22

Upgrade

JP Morgan

Neutral → Overweight

May-31-22

Upgrade

Guggenheim

Neutral → Buy

Apr-25-22

Upgrade

Cowen

Market Perform → Outperform

$130

Apr-12-22

Upgrade

Morgan Stanley

Underweight → Equal-Weight

Mar-16-22

Upgrade

Deutsche Bank

Hold → Buy

Jan-25-22

Downgrade

Liberum

Hold → Sell

Dec-20-21

Downgrade

JP Morgan

Overweight → Neutral

Show Previous Ratings

Mar-31-23 12:52PM	Here's Why Investors Should Hold Ensign Group (ENSG) Stock Now Zacks
12:31PM	Scynexis (SCYX) Inks Antifungal Drug Deal With GSK Zacks
11:12AM	EU backs use of Novo Nordisk's weight loss drug in adolescents Reuters
09:15AM	EU backs use of Novo Nordisk's weight loss drug in adolescents Reuters
Mar-30-23 11:01AM	CORRECTED-UPDATE 1-FOCUS-US doctor groups debate best use of new weight-loss drugs Reuters
09:45AM	Loading…
09:45AM	3 Stocks That Could Benefit From the Ozempic Craze Motley Fool
07:00AM	CORRECTED-FOCUS-US doctor groups debate best use of new weight-loss drugs Reuters
Mar-29-23 04:10PM	Novo Hits Another Record High As WHO Considers A Key Move In Obesity Investor's Business Daily
03:22PM	Novo Nordisk says stopping obesity drug may cause full weight regain in 5 years Reuters
03:07PM	Novo Nordisk's Obesity Drug May Find Place On World Health Organization's 'Essential Medicines List' Benzinga
02:50PM	The WHO will consider adding obesity drugs to the list of essential medicines Quartz
12:51PM	The Government Move That Could Drive Obesity Drugs And Lilly, Novo Shares Investor's Business Daily
11:12AM	Viking (VKTX) Announces Clinical Data for Metabolic Disorders Zacks
05:54AM	Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%? Motley Fool
Mar-28-23 05:50PM	Novo Nordisk (NVO) Gains As Market Dips: What You Should Know Zacks
12:00PM	Loading…
12:00PM	Novo Nordisk (NVO) is a Great Momentum Stock: Should You Buy? Zacks
Mar-27-23 12:06PM	Novo Nordisk (NVO) Meets Semaglutide Higher Dosage Study Goal Zacks
11:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover Morningstar Research
10:07AM	Novo Nordisk A/S - share repurchase programme GlobeNewswire
08:30AM	Here's How Much You'd Have If You Invested $1000 in Novo Nordisk a Decade Ago Zacks
07:50AM	Beat the Market Like Zacks: NVIDIA, SoundHound, Reuters in Focus Zacks
Mar-26-23 08:45AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover Morningstar Research
Mar-25-23 01:38PM	Who Are Pfizer's (PFE) Main Competitors? Investopedia
Mar-24-23 04:04PM	The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win Investor's Business Daily
11:28AM	Oral semaglutide 25 mg and 50 mg demonstrate superior reductions in HbA1c and body weight versus 14 mg in people with type 2 diabetes in the PIONEER PLUS phase 3 trial GlobeNewswire
04:24AM	Obesity Drug Hit Makes Novo Nordisk More Valuable Than Nestle Bloomberg
Mar-23-23 12:14PM	Incyte (INCY) Receives FDA Approval for Skin Cancer Treatment Zacks
11:16AM	Resolutions from the Annual General Meeting of Novo Nordisk A/S GlobeNewswire
09:51AM	AbbVie (ABBV) Gets FDA Rejection for Parkinson's Candidate Zacks
09:50AM	Roche (RHHBY) & Lilly to Co-Develop Alzheimer's Detection Device Zacks
09:30AM	Loading…
09:30AM	Brokers Suggest Investing in Novo Nordisk (NVO): Read This Before Placing a Bet Zacks
07:05AM	The Zacks Analyst Blog Highlights Amazon.com, Novo Nordisk, Qualcomm, Booking Holdings and Chubb Zacks
Mar-22-23 05:45PM	Novo Nordisk (NVO) Stock Moves -0.41%: What You Should Know Zacks
01:33PM	Top Stock Reports for Amazon.com, Novo Nordisk & QUALCOMM Zacks
11:18AM	Here's Why You Should Add Novo (NVO) Stock to Your Portfolio Zacks
09:30AM	Earnings Growth & Price Strength Make Novo Nordisk (NVO) a Stock to Watch Zacks
Mar-21-23 07:37AM	The Zacks Analyst Blog Highlights Credit Suisse, Meta Platforms, Novo Nordisk and Salesforce Zacks
06:24AM	Altimmune shares plunge amid health concerns over obesity drug Investing.com
Mar-20-23 02:45PM	Universal Health (UHS) Up 26% in 6 Months: More Room to Run? Zacks
07:50AM	Novo Nordisk A/S - share repurchase programme GlobeNewswire
06:26AM	Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023? Zacks
Mar-17-23 01:24PM	Novartis (NVS) Oncology Drug Gets FDA Nod for Label Expansion Zacks
12:46PM	UPDATE 2-Novo Nordisk's diabetes drug Ozempic back in supply in US after months of shortage Reuters
12:19PM	Pfizer's (PFE) COVID-19 Drug Paxlovid Gets FDA Panel Vote Zacks
10:15AM	2 Top Healthcare Stocks to Buy for the Long Haul Motley Fool
10:13AM	Sanofi (SNY) to Reduce Lantus Insulin Price by Up to 78% Zacks
10:08AM	Pharma Stock Roundup: M&A Boom in Drug Industry With PFE & SNY Deals, Other Updates Zacks
10:02AM	Three Is Company - Sanofi Follows Lilly, Novo Nordisk, Slashes Insulin Product Price By 78% Benzinga
Mar-16-23 05:45PM	Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know Zacks
04:45PM	UPDATE 3-Sanofi to cut US price of its most-prescribed insulin by 78% Reuters
04:24PM	Sanofi to cap price of Lantus insulin at $35 MarketWatch
02:26PM	Novo Nordisk Suspended From UK Trade Association For Practice Breaches Benzinga
06:02AM	Novo Nordisk suspended from UK industry group after rule violation Financial Times
Mar-15-23 07:11PM	Biden says hes intensely focused on lowering drug prices MarketWatch
02:38PM	Pfizer (PFE) Gets FDA Nod for Bivalent COVID Jab in Infants Zacks
10:39AM	Novo Nordisk (NVO) Follows Lilly, to Cut Insulin Prices by 75% Zacks
10:22AM	AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023? Zacks
01:18AM	PRESS DIGEST- Wall Street Journal - March 15 Reuters
Mar-14-23 12:32PM	Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi Zacks
11:55AM	Novo Nordisk to Slash Insulin Prices by Up to 75% The Wall Street Journal
11:13AM	Novo Nordisk Follows Eli Lilly In Slashing Insulin Prices By 75% Benzinga
10:26AM	Biden stresses inflation report shows slowest annual rise since September 2021 MarketWatch
09:22AM	Midday movers: First Republic, Meta Platforms, Novo Nordisk and more Investing.com
09:00AM	Novo Nordisk plans price cuts for several insulins AP Finance
08:45AM	Novo Nordisk to lower prices of some insulins, following similar move by Lilly MarketWatch
08:30AM	Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024 PR Newswire
08:18AM	UPDATE 6-Novo Nordisk to slash US insulin prices, following move by Eli Lilly Reuters
08:10AM	Novo Nordisk to slash US insulin prices, following move by Eli Lilly Reuters
Mar-13-23 05:50PM	Novo Nordisk (NVO) Dips More Than Broader Markets: What You Should Know Zacks
11:39AM	Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret Zacks
11:34AM	Novo Nordisk A/S - share repurchase programme GlobeNewswire
06:52AM	Novo Nordisk A/S (NVO) Outperformed and Reported 16% Sales Growth in Q4 Insider Monkey
Mar-12-23 08:23AM	Weight Watchers CEO on diabetes drugs for weight loss: 'There's been a lot of misinformation and misuse' Yahoo Finance
Mar-10-23 12:12PM	Roche (RHHBY) Polivy Combo Backed by FDA Advisory Committee Zacks
10:42AM	Neoleukin (NLTX) Up 36% on Initiating Another Restructuring Plan Zacks
10:26AM	AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies Zacks
04:38AM	Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi Zacks
Mar-09-23 09:33AM	Lilly's (LLY) Alzheimer Drug Fails Late-Stage Prevention Study Zacks
08:00AM	5 Large Drug Stocks to Watch as Sector Picks Up in 2023 Zacks
Mar-08-23 12:02PM	Acadia Healthcare (ACHC) to Build Behavioral Health Unit in Mesa Zacks
08:00AM	Merck (MRK) Reports Detailed Data From PAH Study on Sotatercept Zacks
Mar-07-23 06:00AM	Novo Nordisk announces changes in Executive Management GlobeNewswire
05:00AM	The Zacks Analyst Blog Highlights Novo Nordisk, Swisscom and HSBC Zacks
04:24AM	AstraZeneca (AZN) Enhertu Betters Outcomes in Multi-Tumor Study Zacks
03:31AM	Should You Invest in Novo Nordisk A/S (NVO)? Insider Monkey
Mar-06-23 07:20AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Mar-05-23 05:30AM	New Diabetes Drugs Like Ozempic Are Changing How Patients Are Treated The Wall Street Journal
Mar-04-23 08:59AM	AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Rally Gains Steam Investor's Business Daily
Mar-03-23 09:07AM	12 Most Profitable Biotech Stocks Today Insider Monkey
08:30AM	If You Invested $1000 in Novo Nordisk a Decade Ago, This is How Much It'd Be Worth Now Zacks
Mar-02-23 04:10PM	10 Biggest Biotechnology Companies Investopedia
01:33PM	Europe will lose out on medical innovation if draft EU reforms pass, Novo Nordisk CEO says Reuters
09:02AM	Eli Lillys Insulin Price Cap Squeezes Other Drug Makers Barrons.com
07:45AM	4 Low-Beta Stocks to Buy to Combat the Volatile Market Zacks
02:10AM	Novo Nordisk to expand R&D presence in greater Boston area GlobeNewswire
Mar-01-23 01:33PM	CBS '60 Minutes' Story Turns FDA Headlights On Diabetes and Weight Loss Drug Stock Investor's Business Daily
Feb-27-23 04:51PM	CBS '60 Minutes' Gaffe Turns FDA Headlights On Diabetes and Weight Loss Drug Stock Investor's Business Daily
04:04PM	IBD 50 Growth Stock: Diabetes Drugmaker Faces FDA Headlights On CBS '60 Minutes' Ad Investor's Business Daily
10:00AM	What Happens When You Stop Taking Ozempic? The Wall Street Journal
09:10AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience